Skip to main content

Pediatric Resource Use Less Likely With Legalization of Recreational Cannabis

Medically reviewed by Carmen Pope, BPharm. Last updated on May 2, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 1, 2024 -- In cases of cannabis intoxication in children, resource utilization is less likely in states with recreational legalization of cannabis, according to a study published online May 1 in Pediatrics.

Patrick S. Walsh, M.D., from the Medical College of Wisconsin in Milwaukee, and colleagues conducted a cross-sectional study of the Pediatric Health Information System, including emergency department encounters between January 2016 and April 2023 for children aged younger than 6 years with cannabis ingestion to examine whether the legal status of recreational cannabis was associated with resource utilization outcomes.

Data were included for 3,649 children from 47 hospitals; 29 percent of encounters occurred in states where recreational cannabis was legal. The researchers found that cannabis-legal locations had lower use of advanced imaging, lumbar puncture, intensive care unit admission, and mechanical ventilation compared with environments where recreational cannabis was illegal (adjusted odds ratios, 0.65, 0.42, 0.71, and 0.30, respectively). Urine testing occurred more often where recreational cannabis was legal (adjusted odds ratio, 1.87).

"Our findings suggest the need for education on the early recognition and management of cannabis intoxication in young children and a focus on policies and procedures to minimize invasive and potentially harmful testing," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.